Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12609000443291Phase 4Not yet recruiting
Phase 4 trial of adapalene, benzoyl peroxide and lymecycline in acne vulgaris (2 arms), sponsored by Galderma. Primary endpoints: Non-inflammatory lesion count, Inflammatory lesion count and 1 more. Planned start Aug 2009; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12609000443291.